Page last updated: 2024-11-01

octopamine and Diabetic Coma

octopamine has been researched along with Diabetic Coma in 1 studies

Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.

Diabetic Coma: A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zschornack, MR1
Haller, H1

Other Studies

1 other study available for octopamine and Diabetic Coma

ArticleYear
[Directives on the treatment of diabetic coma with special reference to disorders of the water-electrolyte balance. 2].
    Medizinische Klinik, 1965, Sep-10, Volume: 60, Issue:37

    Topics: Anuria; Carbohydrate Metabolism; Carbonates; Diabetic Coma; Diabetic Ketoacidosis; Heart Failure; Hu

1965